...BRCA2 mutations, the risk of future breast cancer is very high, and the performance of a bilateral prophylactic mastecto...
...BRCA2 (BRCA+) mutations. BRCA+ women who underwent risk-reducing bilateral salpingo-oophorectomy were studied (n=74). Fi...
...BRCA2 mutation. We evaluated the performances of currently-used risk models among patients from a large familial program...
...BRCA2 mutation or a strong family history of breast cancer, there is no clear estimation of the risk of tumour induction...
...BRCA2 mutation carriers, respectively. Relevant clinical data, including histology, grade, stage, size of residual tumor...
...BRCA2 mutation completed a self-administered questionnaire. Seventy- two percent (72%) of men attended the familial canc...
...BRCA2 genes. Women who inherit a deleterious mutation in either of these genes have a very high lifetime risk of ovarian...
...BRCA2 carriers. This collective review highlights radiologic screening of patients with this genetic predisposition for ...
...BRCA2, markedly increase the risk of cancers at unusually early ages. Increasing numbers of these highly penetrant genes...
...BRCA2 gene at band 13q12 was found. Detailed deletion mapping at band 13q14 with probes from the RB1-D13S25 interval lea...
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
